Healthcare provider profile · identity verified

Alison Beth Post, MD

Internal Medicine · ALLENTOWN, PA · NPI 1750553871

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	478	132
Levothyroxine Sodium	Levothyroxine Sodium	466	111
Amlodipine Besylate	Amlodipine Besylate	462	131
Lisinopril	Lisinopril	342	97
Losartan Potassium	Losartan Potassium	282	75
Rosuvastatin Calcium	Rosuvastatin Calcium	260	80
Sertraline Hcl	Sertraline Hcl	218	56
Hydrochlorothiazide	Hydrochlorothiazide	197	61
Omeprazole	Omeprazole	189	57
Metformin Hcl	Metformin Hcl	186	53
Simvastatin	Simvastatin	183	52
Gabapentin	Gabapentin	178	51
Eliquis	Apixaban	159	31
Metoprolol Succinate	Metoprolol Succinate	158	50
Pantoprazole Sodium	Pantoprazole Sodium	158	41
Fluticasone Propionate	Fluticasone Propionate	139	49
Trazodone Hcl	Trazodone Hcl	136	43
Famotidine	Famotidine	129	41
Metoprolol Tartrate	Metoprolol Tartrate	118	34
Albuterol Sulfate Hfa	Albuterol Sulfate	102	35
Alprazolam	Alprazolam	102	35
Carvedilol	Carvedilol	99	25
Pravastatin Sodium	Pravastatin Sodium	91	24
Montelukast Sodium	Montelukast Sodium	84	21
Alendronate Sodium	Alendronate Sodium	82	25
Duloxetine Hcl	Duloxetine Hcl	81	25
Jardiance	Empagliflozin	78	16
Furosemide	Furosemide	76	25
Atenolol	Atenolol	70	21
Spironolactone	Spironolactone	61	19
Tamsulosin Hcl	Tamsulosin Hcl	61	15
Synthroid	Levothyroxine Sodium	60	16
Mirtazapine	Mirtazapine	59	18
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	56	56
Ezetimibe	Ezetimibe	56	18
Escitalopram Oxalate	Escitalopram Oxalate	55	16
Metformin Hcl Er	Metformin Hcl	52	18
Venlafaxine Hcl Er	Venlafaxine Hcl	52	13
Tramadol Hcl	Tramadol Hcl	50	18
Citalopram Hbr	Citalopram Hydrobromide	49	12
Mounjaro	Tirzepatide	47	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	12
Allopurinol	Allopurinol	44	13
Clopidogrel	Clopidogrel Bisulfate	44	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	12
Valsartan	Valsartan	41	11
Finasteride	Finasteride	40	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	40	suppressed
Paroxetine Hcl	Paroxetine Hcl	40	14
Ozempic	Semaglutide	39	suppressed
Klor-Con M20	Potassium Chloride	38	11
Meloxicam	Meloxicam	38	14
Clonazepam	Clonazepam	37	suppressed
Irbesartan	Irbesartan	37	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	33	32
Celecoxib	Celecoxib	33	suppressed
Bupropion Xl	Bupropion Hcl	31	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Lorazepam	Lorazepam	31	14
Potassium Chloride	Potassium Chloride	31	15
Amoxicillin	Amoxicillin	30	19
Pioglitazone Hcl	Pioglitazone Hcl	30	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Buspirone Hcl	Buspirone Hcl	27	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	11
Estradiol	Estradiol	27	12
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Glimepiride	Glimepiride	26	suppressed
Methocarbamol	Methocarbamol	26	13
Pregabalin	Pregabalin	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Repaglinide	Repaglinide	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	13
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	25	suppressed
Januvia	Sitagliptin Phosphate	25	11
Meclizine Hcl	Meclizine Hcl	25	13
Valacyclovir	Valacyclovir Hcl	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Cephalexin	Cephalexin	21	17
Bisoprolol Fumarate	Bisoprolol Fumarate	20	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Diazepam	Diazepam	18	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Naproxen	Naproxen	18	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	18	15
Torsemide	Torsemide	18	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Travoprost	Travoprost	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Repatha Sureclick	Evolocumab	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error